Cargando…

Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

The increasing emergence of multidrug-resistant infection causing microorganisms has become a significant burden globally. Despite the efforts of pharmaceuticals in producing relatively new antimicrobial drugs, they have resulted in a high rate of mortality, disability and diseases across the world...

Descripción completa

Detalles Bibliográficos
Autores principales: Okwu, Maureen U., Olley, Mitsan, Akpoka, Augustine O., Izevbuwa, Osazee E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIMS Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642907/
https://www.ncbi.nlm.nih.gov/pubmed/31384707
http://dx.doi.org/10.3934/microbiol.2019.2.117
_version_ 1783437051489681408
author Okwu, Maureen U.
Olley, Mitsan
Akpoka, Augustine O.
Izevbuwa, Osazee E.
author_facet Okwu, Maureen U.
Olley, Mitsan
Akpoka, Augustine O.
Izevbuwa, Osazee E.
author_sort Okwu, Maureen U.
collection PubMed
description The increasing emergence of multidrug-resistant infection causing microorganisms has become a significant burden globally. Despite the efforts of pharmaceuticals in producing relatively new antimicrobial drugs, they have resulted in a high rate of mortality, disability and diseases across the world especially in developing countries. Supporting this claim was the report of the Centre for Disease Control and Prevention (CDC) who estimated that over 2 million illnesses and 23,000 deaths per year are attributable to antibiotic resistant pathogens in the United States. They include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-intermediate Staphylococcus aureus (VISA), Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-resistant enterococci (VRE), Extended spectrum beta-lactamases (ESBLs) producing gram-negative bacilli, Multidrug-resistant Streptococcus pneumoniae (MDRSP), Carbapenem-resistant Enterobacteriaceae (CRE) and Multidrug-resistant Acinetobacter baumannii. For MRSA, resistance is as a result of Methicillin-sensitive S. aureus (MSSA) strains that have acquired Staphylococcal Cassette Chromosome mec (SCCmec) which carries mecA gene. The gene encodes the penicillin-binding protein (PBP2a) which confers resistance to all β-lactam antibiotics. Vancomycin was previously the widely preferred drug for the treatment of MRSA infections. It is no longer the case with the emergence of S. aureus strains with reduced vancomycin sensitivity limiting the conventional treatment options for MRSA infections to very scanty expensive drugs. Presently, many researchers have reported the antibacterial activity of many plant extracts on MRSA. Hence, these medicinal plants might be promising candidates for treatment of MRSA infections. This work is a brief review on Methicillin-resistant Staphylococcus aureus (MRSA) and the anti-MRSA activities of extracts of selected medicinal plants.
format Online
Article
Text
id pubmed-6642907
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AIMS Press
record_format MEDLINE/PubMed
spelling pubmed-66429072019-08-05 Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review Okwu, Maureen U. Olley, Mitsan Akpoka, Augustine O. Izevbuwa, Osazee E. AIMS Microbiol Review The increasing emergence of multidrug-resistant infection causing microorganisms has become a significant burden globally. Despite the efforts of pharmaceuticals in producing relatively new antimicrobial drugs, they have resulted in a high rate of mortality, disability and diseases across the world especially in developing countries. Supporting this claim was the report of the Centre for Disease Control and Prevention (CDC) who estimated that over 2 million illnesses and 23,000 deaths per year are attributable to antibiotic resistant pathogens in the United States. They include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-intermediate Staphylococcus aureus (VISA), Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-resistant enterococci (VRE), Extended spectrum beta-lactamases (ESBLs) producing gram-negative bacilli, Multidrug-resistant Streptococcus pneumoniae (MDRSP), Carbapenem-resistant Enterobacteriaceae (CRE) and Multidrug-resistant Acinetobacter baumannii. For MRSA, resistance is as a result of Methicillin-sensitive S. aureus (MSSA) strains that have acquired Staphylococcal Cassette Chromosome mec (SCCmec) which carries mecA gene. The gene encodes the penicillin-binding protein (PBP2a) which confers resistance to all β-lactam antibiotics. Vancomycin was previously the widely preferred drug for the treatment of MRSA infections. It is no longer the case with the emergence of S. aureus strains with reduced vancomycin sensitivity limiting the conventional treatment options for MRSA infections to very scanty expensive drugs. Presently, many researchers have reported the antibacterial activity of many plant extracts on MRSA. Hence, these medicinal plants might be promising candidates for treatment of MRSA infections. This work is a brief review on Methicillin-resistant Staphylococcus aureus (MRSA) and the anti-MRSA activities of extracts of selected medicinal plants. AIMS Press 2019-04-15 /pmc/articles/PMC6642907/ /pubmed/31384707 http://dx.doi.org/10.3934/microbiol.2019.2.117 Text en © 2019 the Author(s), licensee AIMS Press This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
spellingShingle Review
Okwu, Maureen U.
Olley, Mitsan
Akpoka, Augustine O.
Izevbuwa, Osazee E.
Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title_full Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title_fullStr Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title_full_unstemmed Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title_short Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
title_sort methicillin-resistant staphylococcus aureus (mrsa) and anti-mrsa activities of extracts of some medicinal plants: a brief review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642907/
https://www.ncbi.nlm.nih.gov/pubmed/31384707
http://dx.doi.org/10.3934/microbiol.2019.2.117
work_keys_str_mv AT okwumaureenu methicillinresistantstaphylococcusaureusmrsaandantimrsaactivitiesofextractsofsomemedicinalplantsabriefreview
AT olleymitsan methicillinresistantstaphylococcusaureusmrsaandantimrsaactivitiesofextractsofsomemedicinalplantsabriefreview
AT akpokaaugustineo methicillinresistantstaphylococcusaureusmrsaandantimrsaactivitiesofextractsofsomemedicinalplantsabriefreview
AT izevbuwaosazeee methicillinresistantstaphylococcusaureusmrsaandantimrsaactivitiesofextractsofsomemedicinalplantsabriefreview